116 related articles for article (PubMed ID: 20462756)
1. Synthesis and antibacterial activity of novel 4''-O-arylalkylcarbamoyl and 4''-O-((arylalkylamino)-4-oxo-butyl)carbamoyl clarithromycin derivatives.
Ju Y; Xian R; Zhang L; Ma R; Cao J; Ma S
Bioorg Med Chem Lett; 2010 Jun; 20(11):3272-4. PubMed ID: 20462756
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial activity of novel 4''-O-carbamoyl erythromycin-A derivatives.
Qi Y; Jiao B; Ma X; Cui W; Ma S
Arch Pharm (Weinheim); 2010 Aug; 343(8):458-64. PubMed ID: 20803622
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of novel 3-O-carbamoyl derivatives of clarithromycin and 11,12-cyclic carbonate azithromycin.
Zhang L; Song L; Liu Z; Li H; Lu Y; Li Z; Ma S
Eur J Med Chem; 2010 Mar; 45(3):915-22. PubMed ID: 19945195
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activities of a novel alkylide: 3-O-(3-aryl-2-propargyl) and 3-O-(3-aryl-2-propenyl)clarithromycin derivatives.
Liang JH; Wang YY; Wang H; Li XL; An K; Xu YC; Yao GW
Bioorg Med Chem Lett; 2010 May; 20(9):2880-3. PubMed ID: 20356738
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4''-O-carbamate derivatives.
Ma C; Liu Z; Song H; Jiang R; He F; Ma S
J Antibiot (Tokyo); 2010 Jan; 63(1):3-8. PubMed ID: 19911029
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of novel 15-membered macrolide derivatives: 4''-carbamate, 11,12-cyclic carbonate-4''-carbamate and 11,4''-di-O-arylcarbamoyl analogs of azithromycin.
Ma S; Ma R; Liu Z; Ma C; Shen X
Eur J Med Chem; 2009 Oct; 44(10):4010-20. PubMed ID: 19464769
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of 3-O-carbamoyl derivatives of 6,11-di-O-methylerythromycin A: a novel class of acylides.
Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Guo H; Hu H; Zhou D; Hu X
Eur J Med Chem; 2010 Sep; 45(9):3636-44. PubMed ID: 20554083
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.
Ma S; Jiao B; Ju Y; Zheng M; Ma R; Liu L; Zhang L; Shen X; Ma C; Meng Y; Wang H; Qi Y; Ma X; Cui W
Eur J Med Chem; 2011 Feb; 46(2):556-66. PubMed ID: 21159410
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of 4'',11-di-O-arylalkylcarbamoyl azithromycin derivatives.
Ma S; Jiao B; Liu Z; Wang H; Xian R; Zheng M; Lou H
Bioorg Med Chem Lett; 2009 Mar; 19(6):1698-701. PubMed ID: 19232491
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activities of 6-O-methylerythromycin A 9-O-(3-aryl-2-propenyl) oxime ketolide, 2,3-enol ether, and alkylide analogues.
Liang JH; Dong LJ; Wang H; An K; Li XL; Yang L; Yao GW; Xu YC
Eur J Med Chem; 2010 Sep; 45(9):3627-35. PubMed ID: 20627377
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial activity of novel 4″-O-benzimidazolyl clarithromycin derivatives.
Cong C; Wang H; Hu Y; Liu C; Ma S; Li X; Cao J; Ma S
Eur J Med Chem; 2011 Jul; 46(7):3105-11. PubMed ID: 21524827
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antibacterial activity of a novel alkylide: 3-O-(3-aryl-propenyl)clarithromycin derivatives.
Liang JH; Wang YY; Zhu DY; Dong LJ; An MM; Wang R; Yao GW
J Antibiot (Tokyo); 2009 Nov; 62(11):605-11. PubMed ID: 19713989
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides.
Jia L; Yan M; Shen Y; Qin Y; Qiang S; Ma S
Bioorg Med Chem Lett; 2017 Aug; 27(16):3693-3697. PubMed ID: 28711353
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of 3-keto-6-O-carbamoyl-11,12-cyclic thiocarbamate erythromycin A derivatives.
Zhu B; Marinelli BA; Abbanat D; Foleno BD; Bush K; Macielag MJ
Bioorg Med Chem Lett; 2007 Jul; 17(14):3900-4. PubMed ID: 17502142
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A.
Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Xu Y; Huang W; Long P; Li R; Hu X
J Antibiot (Tokyo); 2010 Jul; 63(7):343-50. PubMed ID: 20448668
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial evaluation of novel 11,4″-disubstituted azithromycin analogs with greatly improved activity against erythromycin-resistant bacteria.
Li X; Ma S; Yan M; Wang Y; Ma S
Eur J Med Chem; 2013 Jan; 59():209-17. PubMed ID: 23229056
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of novel alkylides: 3-O-arylalkyl clarithromycin derivatives with improved antibacterial activities.
Liang JH; Li XL; Wang H; An K; Wang YY; Xu YC; Yao GW
Eur J Med Chem; 2012 Mar; 49():289-303. PubMed ID: 22301216
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of new 4″-O-carbamates of 11,12-cyclic carbonate erythromycin A 6,9-imino ether.
Zhang L; Jiao B; Yang X; Liu L; Ma S
J Antibiot (Tokyo); 2011 Mar; 64(3):243-7. PubMed ID: 21245870
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial evaluation of novel 11-O-aralkylcarbamoyl-3-O-descladinosylclarithromycin derivatives.
Jia L; Wang Y; Wang Y; Qin Y; Hu C; Sheng J; Ma S
Bioorg Med Chem Lett; 2018 Aug; 28(14):2471-2476. PubMed ID: 29880401
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial activity of novel 3-O-arylalkylcarbamoyl-3-O-descladinosyl-9-O-(2-chlorobenzyl)oxime clarithromycin derivatives.
Qin Y; Qiang S; Ji S; Liu Z; Hu C; Ma S
Bioorg Med Chem Lett; 2018 Nov; 28(20):3324-3328. PubMed ID: 30219527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
